Abstract
Peripheral arterial disease refers to the development of atherosclerotic plaque leading to the narrowing of arteries outside the heart. Approximately 16% of adults aged over 55 years have peripheral arterial disease (PAD) in the USA and Western Europe. Approximately 50% of patients with PAD are asymptomatic with their disease detectable only by their ankle brachial index (ABI). In patients that are symptomatic, PAD can lead to lifestyle-limiting claudication, critical limb ischemia, and limb loss. It is estimated that approximately 1.3% of the population have critical limb ischemia which requires limb salvage therapy with endovascular or surgical interventions.
Since PAD is a local manifestation of systemic atherosclerosis, patients are also at two to sixfold risk for other cardiovascular events including coronary artery disease and cerebrovascular disease. This combined with the high prevalence of chronic kidney disease in this population makes patients with PAD one of the most challenging populations to manage medically as well as with endovascular and surgical treatments.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Bosch JL, Hunink MG. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology. 1997;204:87–96.
Mukherjee D, Inahara T. Endarterectomy as the procedure of choice for atherosclerotic occlusive lesions of the common femoral artery. Am J Surg. 1989;157:498–500.
Springhorn ME, Kinney M, Littooy FN, et al. Inflow atherosclerotic disease localized to the common femoral artery: treatment and outcome. Ann Vasc Surg. 1991;5:234–40.
Scheinert D, Scheinert S, Piorkowski C, Braunlich S, Ulrich M, Biamino G, et al. Prevalence and impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol. 2005;45:312–5.
Krankenberg H, Schluter M, Steinkamp HJ, Burgelin K, Scheinert D, Schulte KL, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation. 2007;116:285–92.
Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010;3:267–76.
Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V, et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther. 2006;13:701–10.
Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33:S1–75.
Capek P, McLean GK, Berkowitz HD. Femoropopliteal angioplasty: factors influencing long-term success. Circulation. 1991;83(suppl 2):I70–80.
Johnston KW. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology. 1992;183:767–71.
Matsi PJ, Manninen HI, Vanninen RL, et al. Femoropopliteal angioplasty in patients with claudication: primary and secondary patency in 140 limbs with 1–3 years follow up. Radiology. 1994;191:727–33.
Jeans WD, Amstrong S, Cole SEA, et al. Fate of patients undergoing transluminal angioplasty for lower-limb ischemia. Radiology. 1990;177:559–64.
Murray JG, Apthorp LA, Wilkins RA. Long-segment (>10 cm) femoropopliteal angioplasty: improved technical success and long-term patency. Radiology. 1995;195:158–62.
Gallino A, Mahler F, Probst P, et al. Percutaneous transluminal angioplasty of the arteries of the lower limbs: a 5-year follow-up. Circulation. 1984;70(4):619–23.
Krepel VM, van Andel GJ, van Erp WF, et al. Percutaneous transluminal angioplasty of the femoropopliteal artery: initial and long-term results. Radiology. 1985;156(2):325–8.
Hunink MG, Donaldson MC, Meyerovitz MF, et al. Risks and benefits of femoropopliteal percutaneous balloon angioplasty. J Vasc Surg. 1993;17(1):183–92.
Gray BH, Olin JW. Limitations of percutaneous transluminal angioplasty with stenting for femoropopliteal arterial occlusive disease. Semin Vasc Surg. 1997;10:8–16.
Strecker EPS, Boos IBL, Gottmann D. Femoropopliteal artery stent-placement: evaluation of long-term success. Radiology. 1997;205:375–83.
Rosenfield K, Schainfeld R, Pieczek A, et al. Restenosis of endovascular stents from stent compression. J Am Coll Cardiol. 1997;29:328–38.
Duda SH, Wiesinger B, Richter GM, et al. Sirolimus-eluting stents in SFA obstructions: long-term SIROCCO trial results. CIRSE 2003 annual meeting and postgraduate course. Main Programme and Abstracts: abstr 35.3.2, p. 157.
van Andel GJ, van Erp WF, Krepel VM, et al. Percutaneous transluminal dilatation of the iliac artery: long-term results. Radiology. 1985;156:321–4.
Blankensteijn JD, van Broonhoven TJ, Lampmann L. Role of percutaneous transluminal angioplasty in aorto-iliac reconstruction. J Cardiovasc Surg (Torino). 1986;27:466–8.
Tegtmeyer CJ, Hartwell GD, Selby JB, et al. Results and complications of angioplasty in aortoiliac disease. Circulation. 1991;83(Suppl 2):53–60.
Jorgensen B, Skovgaard N, Norgard J, et al. Percutaneous transluminal angioplasty in 226 iliac artery stenoses: role of the superficial femoral artery for clinical success. Vasa. 1992;21:382–6.
Johnston KW. Iliac arteries: reanalysis of results of balloon angioplasty. Radiology. 1993;186:207–12.
Rholl KS. Percutaneous aortoiliac intervention in vascular disease. In: Baum S, Pentecost MJ, editors. Abram’s angiography, interventional radiology, vol. III. Boston: Little, Brown; 1997. p. 225–61.
Palmaz JC, Laborde JC, Rivera FJ, et al. Stenting of iliac arteries with the Palmaz stent: experience from a multicentric trial. Cardiovasc Intervent Radiol. 1992;15:291–7.
Vorwerk D, Gunther RW. Stent placement in iliac arterial lesions: three years of clinical experience with the Wallstent. Cardiovasc Intervent Radiol. 1992;15:285–90.
Strecker EP, Hagen P, Liermann D, et al. Iliac and femoropopliteal vascular occlusive disease treated with flexible tantalum stents. Cardiovasc Intervent Radiol. 1993;16:158–64.
Wolf YG, Schatz RA, Knowles HJ, et al. Initial experience with the Palmaz stent for aortoiliac stenoses. Ann Vasc Surg. 1993;7:254–61.
Martin EC, Katzen BT, Benenati JF, et al. Multicenter trial of the Wallstent in iliac and femoral arteries. J Vasc Interv Radiol. 1995;6:843–9.
Vorwerk D, Guenther R, Schurmann K, et al. Aortic and iliac stenoses: follow-up results of stent placement after insufficient balloon angioplasty in 118 cases. Radiology. 1996;198:45–8.
Murphy TP, Webb MS, Lambiase RE, et al. Percutaneous revascularization of complex iliac artery stenoses and occlusions with use of Wallstent: three-year experience. J Vasc Interv Radiol. 1996;7:21–7.
Tetteroo E, van der Graaf Y, Bosch JL, The Dutch Iliac Stent Trial Study Group, et al. Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac artery occlusive disease. Lancet. 1998;351:1153–9.
Treiman GS, Schneider PA, Lawrence PF, et al. Does stent placement improve the results of ineffective or complicated iliac artery angioplasty? J Vasc Surg. 1998;28:104–12.
Hassen-Khodja R, Sala F, Declemy S, et al. Value of stent placement during percutaneous transluminal angioplasty of the iliac arteries. J Cardiovasc Surg (Torino). 2001;42:369–74.
Vorwerk D, Guenther R, Schurmann K, et al. Primary stent placement for chronic iliac artery occlusions: follow-up results in 103 patients. Radiology. 1995;194:745–9.
Dyett JF, Gaines PA, Nicholson AA, Cleveland T, et al. Treatment of chronic iliac artery occlusions by means of endovascular stent placement. J Vasc Interv Radiol. 1997;8:349–53.
Henry M, Amor M, Ethevenot G, et al. Percutaneous treatment of iliac occlusions: long-term follow-up in 105 patients. J Endovasc Surg. 1998;5:228–35.
Ballard JL, Bergan JJ, Singh P, et al. Aortoiliac stent deployment versus surgical reconstruction: analysis of outcome and cost. J Vasc Surg. 1998;28:94–101.
Scheinert D, Schroder M, Ludwig J, et al. Stent-supported recanalization of chronic iliac occlusions. Am J Med. 2001;110:708–15.
Uher P, Nyman U, Lindh M, et al. Long-term results for stenting chronic iliac occlusions. J Endovasc Ther. 2002;9:67–75.
Funovics MA, Lackner B, Cejna M, et al. Predictors of long-term results after treatment of iliac artery obliteration by transluminal angioplasty and stent placement. Cardiovasc Intervent Radiol. 2002;25:397–402.
Carnevale FC, De Blas M, Merino S, et al. Percutaneous endovascular treatment of chronic iliac artery occlusion. Cardiovasc Intervent Radiol. 2004;27:447–52.
Soga Y, Lida O, Hirano K, Yokoi H, Nanto S, Nobuyoshi M. Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent. J Vasc Surg. 2010;52:608–15.
Soder HK, Manninen HI, Jaakkola P, et al. Prospective trial of infrapopliteal artery balloon angioplasty for critical limb ischemia. J Vasc Interv Radiol. 2000;11:1021–31.
Lofberg AM, Karacagil S, Ljungman C, et al. Percutaneous transluminal angioplasty of the femoropopliteal arteries in limbs with chronic critical limb ischemia. J Vasc Surg. 2001;34:114–21.
Boyer L, Therre T, Garcier JM, et al. Infra-popliteal percutaneous transluminal angioplasty limb salvage. Acta Radiol. 2000;41:73–7.
London NJ, Varty K, Sayers RD, et al. Percutaneous transluminal angioplasty for lower-limb critical ischemia. Br J Surg. 1996;83:135–6.
Vainio E, Salenius JP, Lepantalo M, et al. Endovascular surgery for chronic lower limb ischemia. Factors predicting immediate outcome on the basis of a nationwide vascular registry. Ann Chir Gynaecol. 2001;90:86–91.
Henry M, Amor M, Ethevenot G, et al. Palmaz stent placement in iliac and femoropopliteal arteries: primary and secondary patency in 310 patients with 2–4-year follow-up. Radiology. 1995;197:167–74.
Kauffmann GW, et al. Four years’ experience with a balloon-expandable endoprosthesis: experimental and clinical application. Radiologe. 1991;31:202–9.
Richter GM, Palmaz JC, Noeldge G, et al. Relationship between blood flow, thrombus, and neointima in stents. J Vasc Interv Radiol. 1999;10:598–604.
Palmaz JC. Balloon expandable intravascular stent. Am J Roentgenol. 1988;150:1263–9.
Golden MA, Hanson SR, Kirkman TR, et al. Healing of polytetrafluoroethylene arterial grafts is influenced by graft porosity. J Vasc Surg. 1990;11:838–45.
Ahmadi R, Schillinger M, Maca T, et al. Femoropopliteal arteries: immediate and long-term results with a Dacron-covered stent-graft. Radiology. 2002;223:345–50.
Jahnke T, Andersen R, Muller-Hulsbeck S, et al. Hemobahn stent-grafts for treatment of femoropoliteal arterial obstructions: midterm results of a prospective trial. J Vasc Interv Radiol. 2003;14:41–55.
Duda SH, Pusich B, Richter G, et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease. Circulation. 2002;106:1505–9.
Acknowledgment
We would like to thank Dr. Jason Martin for his contributions to this chapter (information given on first page of chapter).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Liu, E., Martin, J. (2022). Peripheral Vascular Intervention. In: Athreya, S., Albahhar, M. (eds) Demystifying Interventional Radiology. Springer, Cham. https://doi.org/10.1007/978-3-031-12023-7_19
Download citation
DOI: https://doi.org/10.1007/978-3-031-12023-7_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-12022-0
Online ISBN: 978-3-031-12023-7
eBook Packages: MedicineMedicine (R0)